HOME › DRUGS › DACLATASVIR
ACTIVE SUBSTANCE / INN

DACLATASVIR

Brand name(s): Daklinza
EMA LISTED
EXPIRED
Hepatitis C, Chronic
ACTIVE SUBSTANCE
Daclatasvir
REGULATORS
EMA
SPONSORS / MAH
Bristol-Myers Squibb Pharma EEIG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
DaklinzaBristol-Myers Squibb Pharma EEIGExpired22/08/2014Hepatitis C, Chronic

FULL INTELLIGENCE ON DACLATASVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →